Life sciences and healthcare

Bird & Bird LLP

Client Satisfaction

Praised for its ‘superb knowledge of the industry’ Bird & Bird LLP handles a wide range of work including IP, regulatory, transactional, and commercial law mandates. Mark Hilton co-heads the practice alongside Brussels-based IP expert Marc Martens. Hilton specialises in patent litigation and is active across areas such as high-value patent revocation and infringement proceedings and damages enquiries. Sally Shorthose is well-placed to guide life sciences clients through licensing, partnering and exploitation agreements. Morag Macdonald and Eleanor Root further extend the patent litigation expertise at the firm, while corporate specialist James Baillieu’s expertise extends to venture capital financings and exits. Qualified barrister Chris De Mauny is a key member of the firm’s international patent group. Pieter Erasmus excels in regulatory matters relating to digital health and medical devices.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘Excellent experience, give good commercial advice.’
‘Superb knowledge of the industry. In-depth knowledge of the sector and a solid understanding of the regulatory framework.’

Key clients

Dexcom
CureVac
The Broad Institute
Merck KGaA
Celltrion
Convatec
Gilead Sciences
Teva
Alvotech
WS Audiology

Work highlights

Acting for Dexcom, in multiple international patent infringement and revocation claims against Abbott in relation to their glucose monitoring devices.
Acted for the Dementia Discovery Fund (DDF) and LifeArc on their £9.25 M Series A investment into Cumulus Neuroscience Limited, a digital health company focused on advancing neuroscience clinical trials and patient care through improved data.
Acting for CureVac in patent revocation and infringement proceedings in the UK against BioNTech and Pfizer, and in parallel German infringement proceedings against BioNTech, in relation to their patents in the field of mRNA vaccines.